Stock Appreciation Rights (SARs): How They’re Taxed
What Stock Appreciation Rights Are
A stock appreciation right is a contractual promise to pay you the amount a stock has risen above a set base price between the grant date and the date you exercise. Set the base price at $10, watch the stock climb to $35, and the SAR pays you the $25 of appreciation per share. You never buy anything. Unlike a stock option, where you have to come up with cash to pay the strike price before you see any value, a SAR hands you only the gain, with no purchase on your end and no strike to fund out of pocket. That single difference, the absence of a purchase, is what separates a SAR from an option and drives most of the reasons companies use them.
SARs come in two forms, and which one you have changes what lands in your account. A cash-settled SAR pays the appreciation in cash, so a $25 per-share gain on 1,000 rights writes you a $25,000 check. A stock-settled SAR delivers that same value in shares instead: the company hands you enough stock to equal the $25,000 of appreciation, based on the stock’s value at settlement. Both forms tax the appreciation the same way at settlement, but stock-settled SARs carry an extra wrinkle, because you now hold shares with their own cost basis and their own later sale to report. The IRS equity-based compensation guide (Publication 5992) walks through how appreciation-rights arrangements fit alongside options and full-value awards in the broader equity-comp picture.
One point worth stating plainly: a SAR is not stock and it is not an option. You hold no shares while the SAR is outstanding, you have no voting rights, and you owe nothing until it settles. It is closer to a bonus formula tied to the stock price than to ownership. For a side-by-side of how SARs sit next to options, full-value awards, and purchase plans, the employee stock and equity compensation pillar guide lays out every plan type and where each one is reported.
How SARs Are Taxed at Settlement
Here is the core rule. When a stock appreciation right is exercised and settles, the appreciation paid to you is ordinary income in that year, taxed at your regular rate. There is no special tax status, no holding-period break, and no capital gain treatment on the appreciation itself. The amount paid, whether in cash or in shares, is compensation, and Publication 525, Taxable and Nontaxable Income, treats appreciation-rights payments as exactly that. Settle a SAR with $125,000 of appreciation and you have $125,000 of ordinary income that year, full stop.
That income lands on your Form W-2 in Box 1 wages, and because it is wages it carries the full payroll-tax load: Social Security, Medicare, federal income tax withholding, and state withholding where it applies. Your employer withholds on it the same way it withholds on your salary, which is why a SAR settlement often triggers a same-period tax bite. One caution we give clients: the supplemental withholding rate on this kind of income is frequently a flat 22%, and if your marginal rate is 32% or 37%, that withholding comes up light and you owe the gap at filing. The W-2 figure is right; the withholding is what falls short.
A stock-settled SAR adds a second chapter that a cash SAR does not. When the company delivers shares instead of cash, your cost basis in those shares is their fair market value at settlement, the same amount already taxed as ordinary income. The later sale of those shares is a separate capital transaction. The difference between the sale price and that basis is a capital gain or loss, reported on Form 8949 and carried to Schedule D, with the holding period starting the day after settlement. The appreciation itself is never capital gain; only the movement in the share price after you receive the stock can be. Cash-settled SAR holders skip this entirely, because there are no shares to sell.
Section 409A Is the Rulebook for SARs
A stock appreciation right is a form of nonqualified deferred compensation, which means it lives under Internal Revenue Code Section 409A, the statute that governs the timing of deferred pay. This matters because 409A carries unusually harsh consequences when it is broken, and SARs only escape those consequences if they are designed to fit a specific exemption. Under the Section 409A regulations at Treasury Regulation 1.409A, a SAR is exempt from the harsh 409A rules only if two conditions are met: the base price is set at no less than the fair market value of the stock on the grant date, and the SAR has no feature that defers payment beyond the date it is exercised. Set the base price below grant-date value, or bolt on an extra deferral feature, and the exemption disappears.
Lose the exemption and the result is severe, and it falls on the employee, not the company. A 409A failure triggers immediate income inclusion of the deferred amount, even before it is paid, plus a 20% additional tax on the employee on top of regular income tax, plus an interest charge. So a poorly drafted SAR can tax you on value you have not yet received and then add a 20% penalty on top. This is why the base-price-equals-fair-market-value rule is not a technicality. It is the line between a SAR that is taxed cleanly at settlement and one that detonates a penalty on the holder. The wage side of all this, the ordinary-income treatment at settlement, still runs through your Form W-2 per Publication 525, but whether the timing is clean depends entirely on the 409A design. We read the SAR agreement before settlement to confirm the base price and the payment terms hold up, because the employee is the one who pays for a drafting mistake.
Why Companies Use SARs
Companies reach for stock appreciation rights when they want to give an employee the upside of an option without the baggage that comes with options. The headline reason is that a SAR delivers the gain without making the employee pay a strike price. With a stock option, you cannot capture value until you fund the exercise, which can mean writing a large check or running a cashless exercise through a broker. A SAR skips all of that. The employee receives the appreciation directly, with no cash outlay, which makes the award simpler to understand and easier to value for the person receiving it.
For cash-settled SARs there is a second draw on the company side: no shares change hands. The business pays the appreciation in cash and never issues stock, so the cap table is untouched and existing owners are not diluted. A closely held company that wants to reward key people based on growth in value, but does not want new shareholders with voting rights and information demands, can use cash SARs to tie pay to the stock price without giving up a single share. That combination, upside for the employee and no dilution for the owners, is the reason SARs show up so often in private companies and in the equity packages of senior hires who already understand they are being paid on growth rather than ownership.
SARs vs Options vs Phantom Stock
It helps to set a SAR next to its closest relatives, because the line between them is easy to blur. A non-qualified stock option makes you pay a strike price and then taxes you on the spread between the stock’s value and that strike at exercise. A SAR removes the payment step entirely: it just pays you the same spread, with nothing out of pocket. So an NSO and a SAR can produce the same dollar of appreciation, but the option asks you to fund the purchase first while the SAR does not. For the full mechanics of paying a strike and the 1099-B basis trap that comes with it, our guide on how non-qualified stock options are taxed walks through the option side in detail.
Phantom stock is the other cousin, and the difference there is what gets paid. A SAR pays only the appreciation, the gain above the base price. Phantom stock pays the full value of a notional share, not just the increase, so a phantom unit tracking a $35 stock pays the whole $35 at payout, while a SAR with a $10 base on that same stock pays only the $25 of growth. Both are settled in cash for closely held companies and both produce ordinary W-2 income at payout, but the SAR is a pure upside instrument and phantom stock mirrors the entire share value. Our guide on how phantom stock is taxed covers the full-value side and its own 409A timing rules. For a single side-by-side that lines up SARs, options, full-value awards, and purchase plans on tax and reporting, the plan comparison section of our equity compensation guide puts them in one place.
A Worked Example With Real Dollars
Run the numbers on a concrete grant. You hold 5,000 stock appreciation rights with a $10 base price. Years later you exercise when the stock is worth $35. The appreciation is $25 per share, so the SAR pays out $25 times 5,000, or $125,000. That entire $125,000 is ordinary income in the year of settlement, reported in Box 1 of your Form W-2, with Social Security, Medicare, and income tax withheld just like salary. None of the $125,000 is capital gain, because appreciation paid through a SAR is compensation under Publication 525, not the sale of an asset.
If the SAR is cash-settled, that is the end of the story: you have $125,000 of wages and a tax bill on it that year. If it is stock-settled, the company instead delivers shares worth $125,000, and your cost basis in those shares is $35 per share, the value at settlement. The later sale of those shares is a separate capital transaction. Suppose you hold and sell at $45. Your gain is $10 per share over the $35 basis, reported on Form 8949 and carried to Schedule D, long-term if you held more than a year past settlement. One more layer for higher earners: that capital gain can draw the 3.8% net investment income tax if your modified adjusted gross income clears the threshold, computed on Form 8960. The thresholds are $200,000 for single filers and $250,000 for joint filers, and the IRS net investment income tax page spells out the math. For New York City clients, those thresholds get crossed quickly, so the share sale after a stock-settled SAR is rarely just a clean Schedule D line.
Related Services from The Reed Corporation
Helpful Guides You Might Also Like
Sources & References
Frequently Asked Questions
How are stock appreciation rights taxed?
Stock appreciation rights give you the increase in value of a stated number of shares above a base price fixed at grant, and nothing else. You receive no shares at grant and you own no stock. What you hold is a contract right, and when you exercise it the company pays you the spread between the current fair market value and that base price, either in cash or in shares worth the same amount. Because nothing of value passes to you at grant and nothing passes at vesting, there is no tax at either point. The taxable event is settlement, and the whole spread you receive is ordinary compensation income in that year.
That income behaves exactly like a bonus. It lands on your Form W-2 in box 1, it carries Social Security and Medicare tax, and the employer withholds federal income tax and deposits it under the employment tax rules, reporting the deposits on Form 941. The company takes its compensation deduction in the same year you pick up the income, which is one reason employers like the design. One point catches people who came from a restricted stock background: a section 83(b) election is not available here. That election applies to transferred property, and a contract right to future appreciation is not property that has been transferred, so there is nothing to elect on and no way to start a capital holding period early.
Work an example. An executive holds 10,000 stock appreciation rights with a base price of 15 dollars, granted four years ago. She exercises when the stock trades at 40 dollars. The spread is 25 dollars a share, so 250,000 dollars of ordinary compensation income goes on the W-2 for that year. If the company settles in cash, she receives 250,000 dollars less withholding. If it settles in shares, she receives shares worth 250,000 dollars less the shares held back to cover withholding, and her tax basis in the shares she keeps equals the amount included in income. A later sale produces capital gain or loss measured from that basis and from the settlement date.
The common mistake is assuming the appreciation gets capital gain treatment because the value came from a stock price. It does not. Every dollar of the spread is wage income, taxed at ordinary rates and subject to payroll tax, and only appreciation occurring after settlement can qualify for capital treatment. A second mistake shows up on the sale side. When the award settles in shares and those shares are sold, the broker frequently reports a basis of zero because it has no record of the compensation already taxed. The seller then reports the entire proceeds as gain and pays tax twice on the same money. The correction runs through Form 8949 with the adjusted basis carried to Schedule D.
These awards also differ from phantom stock, which tracks the full value of a share rather than only the appreciation above a base price. The tax result at settlement looks similar, since both produce wage income, but the amount paid is far larger under a phantom design and the section 409A analysis is different. Read the plan document rather than relying on what the award is called in an offer letter, because companies use these labels loosely.
Keeping the settlement statement is the whole defense. It shows the share count, the base price, the market price at settlement, and the amount added to your wages, which together establish your basis for as long as you hold the shares. We file those records inside bookkeeping and carry the figures into individual tax return preparation so the sale year ties back to the settlement year. Treatment at the state level varies, and an employee who worked in more than one state between grant and vesting may find two states claiming a share of the same income.
Check the expiration date on every outstanding grant this quarter, because these awards lapse on a schedule and an unexercised right at expiration is worth nothing regardless of how far the stock has moved.
Do I have to pay anything to exercise stock appreciation rights?
No, and that is the main design feature. A stock option requires you to hand the company cash equal to the strike price times the number of shares before you own anything. Stock appreciation rights require nothing. You tell the company you are exercising, and it pays you the appreciation. There is no purchase, no loan, no cashless exercise arrangement with a broker, and no risk that you buy shares at a price the market later falls below. For an employee who cannot write a large check, that difference decides whether an award is usable at all.
Compare the two on the same facts. An executive holds 10,000 options at a 15 dollar strike with the stock at 40 dollars. Exercising costs 150,000 dollars in cash before any tax is paid, and most people finance that through an immediate sale, which forces a sale decision on the same day as the exercise decision. The same 10,000 awards structured as appreciation rights cost zero to exercise and deliver 250,000 dollars of value directly. The employee still owes ordinary income tax on that 250,000 dollars either way, but only one version demands 150,000 dollars up front from a household that may not have it. The absence of an out of pocket cost also means there is no capital at risk, so nothing about the payout can ever be capital gain.
Settlement method changes what you walk away holding. Cash settlement pays money, withholds from that money, and leaves you with no position and nothing further to track. Share settlement delivers net shares after withholding, which means you now hold employer stock with a basis equal to the income already reported. Those shares carry ordinary investment risk from that point forward, and any further movement is capital gain or loss reported on Form 8949 and Schedule D. Basis conventions for those shares follow the general rules described in Publication 551. Which method applies is usually the company’s choice under the plan, not yours, so read the document before you build a plan around receiving cash.
Something else is missing from these awards that people expect: there are no dividends. You hold no shares before settlement, so no distribution reaches you during the vesting period unless the plan contains a separate dividend equivalent provision, which is uncommon on an appreciation award. That means the entire value of the award depends on price movement above the base price, and a stock that trades flat for the full term delivers nothing at all.
The absence of an exercise cost creates its own trap. Because writing no check feels like taking no action, people exercise on impulse, sometimes late in December, and generate a large slug of wage income in a year already carrying a bonus. Spreading two exercises across two tax years can keep an entire tranche out of the top bracket, and that choice disappears the moment the button is clicked. The common mistake is exactly this, treating a free exercise as a costless one when the tax cost is immediate and large.
A second mistake is holding to expiration in the belief that waiting is always better. These awards have a stated term, often seven or ten years, and an unexercised right on the expiration date is simply gone. Employees who leave a company also face a short post-termination exercise window, frequently 90 days, after which unexercised stock appreciation rights lapse even when fully vested. We track expiration dates and model the tax across alternative exercise years inside tax strategy consulting, then keep the resulting basis records current through bookkeeping. Reporting conventions for securities held after settlement are covered in Publication 550. State rules can differ from the federal answer, particularly where you have changed residence since the grant date.
Pull the term and the post-termination window from each grant agreement and put both dates on a calendar, because the freedom to exercise without cash is worth nothing after the right expires.
How does section 409A apply to stock appreciation rights?
Section 409A governs nonqualified deferred compensation, and an award of this kind either sits outside it or falls squarely inside it based on how the grant was written. The exemption requires four things. The base price can never be less than the fair market value of the underlying stock on the grant date. The number of shares subject to the award has to be fixed at grant. The award can deliver only the appreciation above that base price and nothing more. And the arrangement cannot include any feature that defers payment beyond the exercise date. Meet all four and the ordinary rules described elsewhere on this page apply. Miss one and the award becomes deferred compensation.
The consequences of falling inside section 409A are harsh and they fall on the employee rather than the company. Income becomes taxable as soon as the award vests, not when it is exercised, even though no cash has been received and the employee may have no ability to exercise. On top of the regular income tax, a 20 percent additional tax applies, along with premium interest computed from the year the amount should have been included. The employer reports the amount as wages on Form W-2 and withholds accordingly, and the underlying deposit rules follow the ordinary employment tax framework.
Numbers show the size of the problem. A company grants 20,000 stock appreciation rights with a base price of 6 dollars at a time when a defensible valuation would have put the stock at 10 dollars. The 4 dollar discount destroys the exemption. When the award vests three years later with the stock at 14 dollars, the employee has 160,000 dollars of income that year without receiving a cent, roughly 59,200 dollars of regular federal tax at 37 percent, plus a 20 percent additional tax of 32,000 dollars, plus premium interest. The employee owes more than 91,000 dollars on an award that has not been exercised and cannot be sold.
Private companies carry the real exposure here because the base price depends on a valuation nobody can look up. Section 409A gives a presumption of reasonableness to a valuation performed by an independent appraiser within the prior twelve months, provided nothing material has changed since. The common mistake is granting off a stale number. A board approves awards in November using a valuation dated the prior January, after a funding round and a strong revenue year, and the base price sits below actual value on the grant date. A related mistake is approving a grant by written consent weeks after telling an employee the price, which can move the grant date to a later day with a higher value.
Some defects can be corrected under the IRS correction programs if they are caught in the same year the award is granted or before it vests, which is why an annual review of outstanding grants pays for itself at a company that issues equity regularly. Where a correction is not available, the income has to be reported and the additional tax paid, and an amended return on Form 1040-X is sometimes part of cleaning up prior years. We review grant documentation and valuation timing in tax strategy consulting and handle the reporting through individual tax return preparation, working alongside the attorney who drafted the plan and the appraiser who set the value. Several states impose their own additional tax on the same income, so the federal figure understates the total.
Ask for the valuation date behind your base price before you accept the next grant, because the exemption is decided on the grant date and no later action restores it.
Why does the withholding on a settlement fall short of what I owe?
Because the employer is following a flat rate rather than your actual bracket. A settlement is a supplemental wage payment, and the standard method applies a flat 22 percent federal rate to supplemental wages up to 1,000,000 dollars in a calendar year, with 37 percent applied to any excess above that figure. For an employee whose marginal rate is 22 percent, the withholding is about right. For anyone in the 32 percent bracket or higher, it is not close, and the gap grows with the size of the award. Nothing on the settlement statement flags the difference, and payroll is not doing anything wrong by using the flat method.
Take the executive with 10,000 rights at a 15 dollar base who exercised at 40 dollars, producing 250,000 dollars of wage income. The employer withheld 55,000 dollars at the flat rate. Her household sits in the 35 percent bracket, so the real federal income tax on that amount is 87,500 dollars, and the additional Medicare tax of 0.9 percent on wages above the threshold adds 2,250 dollars. The shortfall is roughly 34,750 dollars before any state tax. Payroll withholding on her regular salary is calibrated to her salary alone and does nothing to absorb it, so the money simply has to come from somewhere else by the filing deadline.
The repair is timing. Federal estimated payments run on Form 1040-ES with due dates in April, June, September, and the following January. Catch a shortfall in the second quarter and it spreads across three payments of about 11,600 dollars each. Catch it in February and it arrives as one payment plus an underpayment penalty computed on Form 2210, since the penalty is charged quarter by quarter rather than on the April balance. The safe harbor tests that avoid the penalty entirely are set out in Publication 505. A payment made by the January date still stops the penalty from running further even though it cannot undo the earlier quarters.
The common mistake is relying on the prior year safe harbor without checking which version applies. Paying in 100 percent of last year’s tax protects most taxpayers, but a household whose prior year adjusted gross income exceeded 150,000 dollars has to reach 110 percent instead. A large settlement often pushes a client past that line in the same year they were counting on the cushion. Increasing payroll withholding on regular salary is frequently the better fix, because withholding is treated as paid evenly throughout the year regardless of when it actually occurred, which can cure an earlier quarter that an estimated payment cannot. Some employers will also apply a higher withholding rate on request when the supplemental payment is aggregated with regular wages, and asking costs nothing.
Multi-state exposure is the piece almost everyone misses. States generally source this income to where you performed services between the grant date and the vesting date, so an employee who spent two of four vesting years working in a high-tax state may owe that state a share even after moving away. The credit for taxes paid to another state usually prevents true double taxation, but it requires filing in both places and the credit is capped at the tax your home state would have charged on the same income. Running the withholding estimator right after a settlement takes a few minutes and gives you the federal number. We size the full picture, including state allocation, through tax strategy consulting and carry it into the individual tax return, coordinating with your payroll department where a withholding change is the cleaner path.
Set aside the difference between the flat rate and your actual bracket on the day a settlement clears, because that money is already owed and every month it stays in your checking account makes the April conversation worse.
Does The Reed Corporation advise me on when to exercise stock appreciation rights?
Not as an investment matter. The Reed Corporation is a CPA and tax firm. We are not a registered investment adviser, we do not manage portfolios, we do not sell securities, and we do not tell anyone whether to hold a position or sell it. Whether your employer’s stock is likely to rise is a question for your own licensed investment advisor, and questions about the grant agreement itself belong to your attorney. What we provide is the tax consequence of each path, expressed in dollars, so the people advising you on the rest are working from accurate numbers rather than estimates. That division of labor is not a formality. It keeps each professional inside the work they are licensed to do.
The tax side of an exercise decision is substantial on its own. Exercising two tranches in one year instead of splitting them across two can push a large slice of income from the 32 percent bracket into 37 percent, and the additional Medicare tax on wages above the threshold rides along with it. A year with a low bonus or an unpaid leave may absorb an exercise at a lower cost than a record year would. Charitable timing, a spouse’s income change, and the sale of a business all move the answer. We build that comparison, then size the payments through Form 1040-ES so the cash is scheduled rather than discovered.
After a share settlement the work shifts to basis. A client received shares worth 180,000 dollars in a net settlement and sold them fourteen months later for 205,000 dollars. The correct result is 25,000 dollars of long-term capital gain, roughly 5,000 dollars of federal tax at 20 percent plus 950 dollars of net investment income tax computed on Form 8960. The broker reported a basis of zero because it had no record of the compensation already taxed, which would have produced a 205,000 dollar gain and about 48,950 dollars of tax. The correction is a basis adjustment on Form 8949 supported by the settlement statement, and it saved roughly 43,000 dollars on one sale.
The common mistake is assuming the brokerage figure must be right because it appears on a federal information return. Brokers report what their own rules require, and for equity compensation those rules leave the compensation element out. A second mistake is discarding settlement statements after the year closes. Those documents are the only proof of basis, and they matter for as long as you hold the shares, which can be a decade. Sales flow to Schedule D, and an adjustment supported by contemporaneous records is routine rather than contentious. Keep the grant agreement itself as well, since the base price and the vesting dates in that document support the state allocation years later.
Clients holding several outstanding grants generally get more from a planning session before an exercise window opens than from a review after the fact, and you can request a consultation to arrange one. In that meeting we map each grant with its base price, vesting dates, and expiration, model the tax on alternative exercise years, allocate income across states where you worked during the vesting period, set the estimated payment schedule, and give your investment advisor a clean basis file for their side of the decision. Continuing work runs through tax strategy consulting, with annual filing and basis tracking through individual tax return preparation. We do not promise a particular tax outcome and no return is beyond an audit, but documented basis and funded estimates address the two failures we see most often on these awards.
Bring your grant agreements and the last two settlement statements to that first meeting, because the planning that changes the number has to happen before you exercise rather than after the income is already reported.